The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Infectious Disease Testing-Global Market Insights and Sales Trends 2024
Synopsis
In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection.
The global Infectious Disease Testing market size is expected to reach US$ 21090 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029. The market is mainly driven by the significant applications of Infectious Disease Testing in various end use industries. The expanding demands from the Hospitals/Clinical Laboratories, Reference Laboratories, Academic/Research Institutes and Other, are propelling Infectious Disease Testing market. Immunodiagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Clinical Microbiology segment is estimated at % CAGR for the next seven-year period.
Biochemical tests used in the identification of infectious agents include the detection of metabolic or enzymatic products characteristic of a particular infectious agent. Since bacteria ferment carbohydrates in patterns characteristic of their genus and species, the detection of fermentation products is commonly used in bacterial identification. Acids, alcohols and gases are usually detected in these tests when bacteria are grown in selective liquid or solid media.
Report Objectives
This report provides market insight on the different segments, by players, by Technology, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Infectious Disease Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Infectious Disease Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Infectious Disease Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Infectious Disease Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Infectious Disease Testing covered in this report include Abbott Diagnostics, Abbott, Beckman Coulter Diagnostics, Roche, Siemens Healthcare, Abaxis, Acon Laboratories, Avioq and BD, etc.
The global Infectious Disease Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Diagnostics
Abbott
Beckman Coulter Diagnostics
Roche
Siemens Healthcare
Abaxis
Acon Laboratories
Avioq
BD
Bio-Rad Laboratories
Cavidi
Cepheid
Chembio Diagnostic Systems
Clarity Diagnostics
EMD Millipore
Epitope Diagnostic
Gold Standard Diagnostics
Hologic
Immunetics
InBios International
Life Technologies
Maxim Biomedical
Global Infectious Disease Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Infectious Disease Testing market, Segment by Technology:
Immunodiagnostics
Clinical Microbiology
PCR
INAAT
DNA Sequencing & NGS
DNA Microarrays
Other
Global Infectious Disease Testing market, by Application
Hospitals/Clinical Laboratories
Reference Laboratories
Academic/Research Institutes
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Technology, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Infectious Disease Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection.
The global Infectious Disease Testing market size is expected to reach US$ 21090 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029. The market is mainly driven by the significant applications of Infectious Disease Testing in various end use industries. The expanding demands from the Hospitals/Clinical Laboratories, Reference Laboratories, Academic/Research Institutes and Other, are propelling Infectious Disease Testing market. Immunodiagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Clinical Microbiology segment is estimated at % CAGR for the next seven-year period.
Biochemical tests used in the identification of infectious agents include the detection of metabolic or enzymatic products characteristic of a particular infectious agent. Since bacteria ferment carbohydrates in patterns characteristic of their genus and species, the detection of fermentation products is commonly used in bacterial identification. Acids, alcohols and gases are usually detected in these tests when bacteria are grown in selective liquid or solid media.
Report Objectives
This report provides market insight on the different segments, by players, by Technology, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Infectious Disease Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Infectious Disease Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Infectious Disease Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Infectious Disease Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Infectious Disease Testing covered in this report include Abbott Diagnostics, Abbott, Beckman Coulter Diagnostics, Roche, Siemens Healthcare, Abaxis, Acon Laboratories, Avioq and BD, etc.
The global Infectious Disease Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Diagnostics
Abbott
Beckman Coulter Diagnostics
Roche
Siemens Healthcare
Abaxis
Acon Laboratories
Avioq
BD
Bio-Rad Laboratories
Cavidi
Cepheid
Chembio Diagnostic Systems
Clarity Diagnostics
EMD Millipore
Epitope Diagnostic
Gold Standard Diagnostics
Hologic
Immunetics
InBios International
Life Technologies
Maxim Biomedical
Global Infectious Disease Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Infectious Disease Testing market, Segment by Technology:
Immunodiagnostics
Clinical Microbiology
PCR
INAAT
DNA Sequencing & NGS
DNA Microarrays
Other
Global Infectious Disease Testing market, by Application
Hospitals/Clinical Laboratories
Reference Laboratories
Academic/Research Institutes
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Technology, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Infectious Disease Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Infectious Disease Testing
1.1 Infectious Disease Testing Market Overview
1.1.1 Infectious Disease Testing Product Scope
1.1.2 Infectious Disease Testing Market Status and Outlook
1.2 Global Infectious Disease Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Infectious Disease Testing Market Size by Region (2018-2029)
1.4 Global Infectious Disease Testing Historic Market Size by Region (2018-2023)
1.5 Global Infectious Disease Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Infectious Disease Testing Market Size (2018-2029)
1.6.1 North America Infectious Disease Testing Market Size (2018-2029)
1.6.2 Europe Infectious Disease Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Infectious Disease Testing Market Size (2018-2029)
1.6.4 Latin America Infectious Disease Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Infectious Disease Testing Market Size (2018-2029)
2 Infectious Disease Testing Market by Technology
2.1 Introduction
2.1.1 Immunodiagnostics
2.1.2 Clinical Microbiology
2.1.3 PCR
2.1.4 INAAT
2.1.5 DNA Sequencing & NGS
2.1.6 DNA Microarrays
2.1.7 Other
2.2 Global Infectious Disease Testing Market Size by Technology: 2018 VS 2022 VS 2029
2.2.1 Global Infectious Disease Testing Historic Market Size by Technology (2018-2023)
2.2.2 Global Infectious Disease Testing Forecasted Market Size by Technology (2024-2029)
2.3 Key Regions Market Size by Technology
2.3.1 North America Infectious Disease Testing Revenue Breakdown by Technology (2018-2029)
2.3.2 Europe Infectious Disease Testing Revenue Breakdown by Technology (2018-2029)
2.3.3 Asia-Pacific Infectious Disease Testing Revenue Breakdown by Technology (2018-2029)
2.3.4 Latin America Infectious Disease Testing Revenue Breakdown by Technology (2018-2029)
2.3.5 Middle East and Africa Infectious Disease Testing Revenue Breakdown by Technology (2018-2029)
3 Infectious Disease Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals/Clinical Laboratories
3.1.2 Reference Laboratories
3.1.3 Academic/Research Institutes
3.1.4 Other
3.2 Global Infectious Disease Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Infectious Disease Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Infectious Disease Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Infectious Disease Testing Revenue Breakdown by Application (2018-2029)
4 Infectious Disease Testing Competition Analysis by Players
4.1 Global Infectious Disease Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Infectious Disease Testing as of 2022)
4.3 Date of Key Players Enter into Infectious Disease Testing Market
4.4 Global Top Players Infectious Disease Testing Headquarters and Area Served
4.5 Key Players Infectious Disease Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Infectious Disease Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Diagnostics
5.1.1 Abbott Diagnostics Profile
5.1.2 Abbott Diagnostics Main Business
5.1.3 Abbott Diagnostics Infectious Disease Testing Products, Services and Solutions
5.1.4 Abbott Diagnostics Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Diagnostics Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott Infectious Disease Testing Products, Services and Solutions
5.2.4 Abbott Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 Beckman Coulter Diagnostics
5.3.1 Beckman Coulter Diagnostics Profile
5.3.2 Beckman Coulter Diagnostics Main Business
5.3.3 Beckman Coulter Diagnostics Infectious Disease Testing Products, Services and Solutions
5.3.4 Beckman Coulter Diagnostics Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Roche Recent Developments
5.4 Roche
5.4.1 Roche Profile
5.4.2 Roche Main Business
5.4.3 Roche Infectious Disease Testing Products, Services and Solutions
5.4.4 Roche Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Roche Recent Developments
5.5 Siemens Healthcare
5.5.1 Siemens Healthcare Profile
5.5.2 Siemens Healthcare Main Business
5.5.3 Siemens Healthcare Infectious Disease Testing Products, Services and Solutions
5.5.4 Siemens Healthcare Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Siemens Healthcare Recent Developments
5.6 Abaxis
5.6.1 Abaxis Profile
5.6.2 Abaxis Main Business
5.6.3 Abaxis Infectious Disease Testing Products, Services and Solutions
5.6.4 Abaxis Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Abaxis Recent Developments
5.7 Acon Laboratories
5.7.1 Acon Laboratories Profile
5.7.2 Acon Laboratories Main Business
5.7.3 Acon Laboratories Infectious Disease Testing Products, Services and Solutions
5.7.4 Acon Laboratories Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Acon Laboratories Recent Developments
5.8 Avioq
5.8.1 Avioq Profile
5.8.2 Avioq Main Business
5.8.3 Avioq Infectious Disease Testing Products, Services and Solutions
5.8.4 Avioq Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Avioq Recent Developments
5.9 BD
5.9.1 BD Profile
5.9.2 BD Main Business
5.9.3 BD Infectious Disease Testing Products, Services and Solutions
5.9.4 BD Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.9.5 BD Recent Developments
5.10 Bio-Rad Laboratories
5.10.1 Bio-Rad Laboratories Profile
5.10.2 Bio-Rad Laboratories Main Business
5.10.3 Bio-Rad Laboratories Infectious Disease Testing Products, Services and Solutions
5.10.4 Bio-Rad Laboratories Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Bio-Rad Laboratories Recent Developments
5.11 Cavidi
5.11.1 Cavidi Profile
5.11.2 Cavidi Main Business
5.11.3 Cavidi Infectious Disease Testing Products, Services and Solutions
5.11.4 Cavidi Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Cavidi Recent Developments
5.12 Cepheid
5.12.1 Cepheid Profile
5.12.2 Cepheid Main Business
5.12.3 Cepheid Infectious Disease Testing Products, Services and Solutions
5.12.4 Cepheid Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.12.5 Cepheid Recent Developments
5.13 Chembio Diagnostic Systems
5.13.1 Chembio Diagnostic Systems Profile
5.13.2 Chembio Diagnostic Systems Main Business
5.13.3 Chembio Diagnostic Systems Infectious Disease Testing Products, Services and Solutions
5.13.4 Chembio Diagnostic Systems Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.13.5 Chembio Diagnostic Systems Recent Developments
5.14 Clarity Diagnostics
5.14.1 Clarity Diagnostics Profile
5.14.2 Clarity Diagnostics Main Business
5.14.3 Clarity Diagnostics Infectious Disease Testing Products, Services and Solutions
5.14.4 Clarity Diagnostics Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.14.5 Clarity Diagnostics Recent Developments
5.15 EMD Millipore
5.15.1 EMD Millipore Profile
5.15.2 EMD Millipore Main Business
5.15.3 EMD Millipore Infectious Disease Testing Products, Services and Solutions
5.15.4 EMD Millipore Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.15.5 EMD Millipore Recent Developments
5.16 Epitope Diagnostic
5.16.1 Epitope Diagnostic Profile
5.16.2 Epitope Diagnostic Main Business
5.16.3 Epitope Diagnostic Infectious Disease Testing Products, Services and Solutions
5.16.4 Epitope Diagnostic Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.16.5 Epitope Diagnostic Recent Developments
5.17 Gold Standard Diagnostics
5.17.1 Gold Standard Diagnostics Profile
5.17.2 Gold Standard Diagnostics Main Business
5.17.3 Gold Standard Diagnostics Infectious Disease Testing Products, Services and Solutions
5.17.4 Gold Standard Diagnostics Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.17.5 Gold Standard Diagnostics Recent Developments
5.18 Hologic
5.18.1 Hologic Profile
5.18.2 Hologic Main Business
5.18.3 Hologic Infectious Disease Testing Products, Services and Solutions
5.18.4 Hologic Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.18.5 Hologic Recent Developments
5.19 Immunetics
5.19.1 Immunetics Profile
5.19.2 Immunetics Main Business
5.19.3 Immunetics Infectious Disease Testing Products, Services and Solutions
5.19.4 Immunetics Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.19.5 Immunetics Recent Developments
5.20 InBios International
5.20.1 InBios International Profile
5.20.2 InBios International Main Business
5.20.3 InBios International Infectious Disease Testing Products, Services and Solutions
5.20.4 InBios International Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.20.5 InBios International Recent Developments
5.21 Life Technologies
5.21.1 Life Technologies Profile
5.21.2 Life Technologies Main Business
5.21.3 Life Technologies Infectious Disease Testing Products, Services and Solutions
5.21.4 Life Technologies Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.21.5 Life Technologies Recent Developments
5.22 Maxim Biomedical
5.22.1 Maxim Biomedical Profile
5.22.2 Maxim Biomedical Main Business
5.22.3 Maxim Biomedical Infectious Disease Testing Products, Services and Solutions
5.22.4 Maxim Biomedical Infectious Disease Testing Revenue (US$ Million) & (2018-2023)
5.22.5 Maxim Biomedical Recent Developments
6 North America
6.1 North America Infectious Disease Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Infectious Disease Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Infectious Disease Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Infectious Disease Testing Market Dynamics
11.1 Infectious Disease Testing Industry Trends
11.2 Infectious Disease Testing Market Drivers
11.3 Infectious Disease Testing Market Challenges
11.4 Infectious Disease Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
